Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn

Pandemic’s Endemic State In 2023 Puts Correction On Testing Revenues

Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.

Shutterstock

While leading medical device companies, notably Johnson & Johnson, scored revenue gains in 2023, for in vitro diagnostics manufacturers it was largely a different story.

The COVID-19 bubble for medtech businesses has been deflating for some time, most visibly in terms of rapid diagnostic test revenues as

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight